{
  "query": "registration number",
  "timestamp": "2025-09-06 08:24:06",
  "config": {
    "top_k": 5,
    "similarity_threshold": 0.0,
    "reranking_enabled": true,
    "hybrid_search_enabled": true,
    "hybrid_search_weight": 0.7
  },
  "results": [
    {
      "id": 1,
      "text": "2-6 \nActivities, value chain and other business \nrelationships \np7 AR2023 Patient care, what makes our heart beat \np39 AR2023 A committed company / society / supply chain \np47 AR2023 Management report / review of IBA activity sectors \np102 AR2023 Management report / significant acquisitions and divestments in 2023 \np108 AR2023 IFRS consolidated financial \n2-7 \nEmployees \np31 AR2023 A committed company \np66 AR2023 Management report / corporate governance statement / diversity, equity and inclusion policy \np80 AR2023 Management report / corporate governance statement / codes of \nconduct \np191 AR",
      "similarity_score": 0.05073720613688716,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 1046,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 2,
      "text": "munication of critical concerns \np51 AR2023 Management report / principal risks and uncertainties faced by the \ncompany \np80 AR2023 Management report / corporate governance statement / codes of \nconduct",
      "similarity_score": 0.04942783309643112,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 1050,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 3,
      "text": "e employees that have continuous \naccess to sensitive financial data (recurring \ninsiders) \nhave \nsigned \nthe \nCode \nfor \nacknowledgment and consent. Details of transactions by executives involving \nthe Company's shares are available in the \nremuneration report. The Dealing Code is available on the Company's \nwebsite \nwww.iba-worldwide.com, on \nthe \nfollowing \npage \nhttps://iba-\nworldwide.com/content/dealing-code \nThe closing periods for the year 2022 were: from February 22, 2023, to March 23, 2023, for the annual report; from 1st August, 2023, to August 30, 2023, for the mid-year report.",
      "similarity_score": 0.05276963349807401,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 461,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 4,
      "text": "ately disclosed or otherwise misleading. In light of the \nprocedures we have performed, there are no material misstatements we have to report to you. The non-financial information required by virtue of article 3:32, 2 of the Companies' and Associations' \nCode is included in the directors report on the consolidated accounts. The Company has prepared the \nnon-financial information, based on Global Reporting Initiatives (here under GRI ). However, in \naccordance with article 3:80, 1, 5 of the Companies' and Associations' Code, we do not express an \nopinion as to whether the non-financial informat",
      "similarity_score": 0.055694308617030085,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 1019,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    },
    {
      "id": 5,
      "text": "its kind for \nIBA). Instead, the remaining amount of variable consideration that is highly sensitive to factors outside the entitys influence \nwas recognized as a refund liability until the uncertainty associated with the variable consideration is resolved. The \nperformance bond was officially reduced to EUR 10 million in December 2021, to EUR 5 million in December 2022 at \nwhich point IBA recognised the corresponding variable consideration in the income statement of respective years.",
      "similarity_score": 0.051670976412466096,
      "metadata": {
        "filename": "annual_report_text (1).txt",
        "filepath": "input\\annual_report_text (1).txt",
        "chunk_id": 738,
        "start_char_idx": 0,
        "end_char_idx": 0,
        "page": null,
        "section": null
      }
    }
  ]
}